Found: 21
Select item for more details and to access through your institution.
Are we ready to use TMB in breast cancer clinical practice?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 1989, doi. 10.1007/s00262-020-02593-w
- By:
- Publication type:
- Article
Observations on neuroimmunomodulation as a novel therapeutic strategy in metastasis.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Sex differences in the association between tumor growth and T cell response in a melanoma mouse model.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2157, doi. 10.1007/s00262-020-02643-3
- By:
- Publication type:
- Article
NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2147, doi. 10.1007/s00262-020-02615-7
- By:
- Publication type:
- Article
Therapeutic ISCOMATRIX™ adjuvant vaccine elicits effective anti-tumor immunity in the TRAMP-C1 mouse model of prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 1959, doi. 10.1007/s00262-020-02597-6
- By:
- Publication type:
- Article
Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2063, doi. 10.1007/s00262-020-02603-x
- By:
- Publication type:
- Article
Economic evaluations of cancer immunotherapy: a systematic review and quality evaluation.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 1947, doi. 10.1007/s00262-020-02646-0
- By:
- Publication type:
- Article
Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2139, doi. 10.1007/s00262-020-02614-8
- By:
- Publication type:
- Article
Successful treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis with triple combination therapy: a case report.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2033, doi. 10.1007/s00262-020-02600-0
- By:
- Publication type:
- Article
Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2053, doi. 10.1007/s00262-020-02611-x
- By:
- Publication type:
- Article
Prevention of liver metastases through perioperative acute CpG-C immune stimulation.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2021, doi. 10.1007/s00262-020-02596-7
- By:
- Publication type:
- Article
Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2125, doi. 10.1007/s00262-020-02610-y
- By:
- Publication type:
- Article
Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2041, doi. 10.1007/s00262-020-02608-6
- By:
- Publication type:
- Article
A TLR4–TRIF-dependent signaling pathway is required for protective natural tumor-reactive IgM production by B1 cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2113, doi. 10.1007/s00262-020-02607-7
- By:
- Publication type:
- Article
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2075, doi. 10.1007/s00262-020-02606-8
- By:
- Publication type:
- Article
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2101, doi. 10.1007/s00262-020-02605-9
- By:
- Publication type:
- Article
PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2089, doi. 10.1007/s00262-020-02604-w
- By:
- Publication type:
- Article
Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2001, doi. 10.1007/s00262-020-02599-4
- By:
- Publication type:
- Article
Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 1973, doi. 10.1007/s00262-020-02598-5
- By:
- Publication type:
- Article
The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2009, doi. 10.1007/s00262-020-02590-z
- By:
- Publication type:
- Article